Home› Funds› UTI Balanced Advantage Fund - Direct Plan - Growth

UTI Balanced Advantage Fund - Direct Plan - Growth Option

UTI · Balanced Advantage
Moderate
₹13.35
Current NAV
05 Nov 2026
0.4%
1Y Return
9.6%
3Y CAGR
13.7%
5Y CAGR
Watchlist
NAV History (1 Year)
Analysis & Suitability
Pros / Upsides
  • Highly cost-efficient with a low expense ratio of 0.32%.
  • Excellent risk-adjusted performance (Sharpe Ratio: 1.62).
  • Well-diversified portfolio aligned with the Balanced Advantage mandate.
Cons / Risks
  • Returns are subject to standard market fluctuations and interest rate risks.
  • No indexation benefits under current tax laws for short holding periods.

Suitable for
  • Systematic investments (SIP) for long-term target goal-based planning.
Not suitable for
  • Short-term trading or speculative investment horizons.

Risk Profile: Moderate Risk
Low Moderate High Very High
Risk Metrics
1.62
Sharpe Ratio
1.52
Beta
-1.88
Alpha
2.14
Sortino
Fund Details
Fund House UTI
Category Balanced Advantage
AUM ₹670 Cr
Expense Ratio 0.32%
Min SIP ₹500
Min Lumpsum ₹1000
Similar Funds in Balanced Advantage
The Wealth Company Balanced Advantage Fund - Direct Growth
The Wealth Company Balanced Advantage
₹9.94 19.6%
The Wealth Company Balanced Advantage Fund - Regular Growth
The Wealth Company Balanced Advantage
₹9.80 17.4%
The Wealth Company Balanced Advantage Fund - Regular IDCW
The Wealth Company Balanced Advantage
₹9.80 13.6%
Nippon India Balanced Advantage Fund - Direct Plan Growth Plan - Bonus Option
Nippon India
₹9.68 11.6%